AstraZeneca PLC (NYSE:AZN)

39.02
Delayed Data
As of 4:00pm ET
 +0.36 / +0.93%
Today’s Change
34.38
Today|||52-Week Range
43.30
+2.74%
Year-to-Date
Zwj Investment Counsel Inc Buys Ingredion Inc, Outfront Media Inc, Citizens Financial...
May 21 / GuruFocus NewsGURU - Paid Partner Content
3 Top Diabetes Stocks to Watch in May
May 15 / MotleyFool.com - Paid Partner Content
Rigel Initiates Enrollment in Pivotal Blood Disorder Study
May 17 / Zacks.comZAK - Paid Partner Content
AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark
May 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.66
Today’s open39.01
Day’s range38.90 - 39.32
Volume3,085,318
Average volume (3 months)5,341,866
Market cap$103.1B
Data as of 4:00pm ET, 05/24/2019

Growth & Valuation

Earnings growth (last year)-29.11%
Earnings growth (this year)+1.57%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)-2.88%
P/E ratio41.1
Price/Sales4.36
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.19+0.48%
SNYSanofi+0.17+0.40%
NVONovo Nordisk+0.21+0.43%
LLYEli Lilly and Co-0.02-0.02%
Data as of 4:04pm ET, 05/24/2019

Financials

Next reporting dateOctober 24, 2019
EPS forecast (this quarter)$0.33
Annual revenue (last year)$22.1B
Annual profit (last year)$2.2B
Net profit margin9.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts